SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-006417
Filing Date
2017-08-09
Accepted
2017-08-09 16:03:27
Documents
83
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bgne-20170630x10q.htm 10-Q 2160963
2 EX-31.1 bgne-20170630ex3111e4c69.htm EX-31.1 16708
3 EX-31.2 bgne-20170630ex31204f8ae.htm EX-31.2 17065
4 EX-32.1 bgne-20170630ex32170413c.htm EX-32.1 13526
  Complete submission text file 0001558370-17-006417.txt   6516714

Data Files

Seq Description Document Type Size
5 EX-101.INS bgne-20170630.xml EX-101.INS 1096134
6 EX-101.SCH bgne-20170630.xsd EX-101.SCH 55309
7 EX-101.CAL bgne-20170630_cal.xml EX-101.CAL 62662
8 EX-101.DEF bgne-20170630_def.xml EX-101.DEF 167066
9 EX-101.LAB bgne-20170630_lab.xml EX-101.LAB 463034
10 EX-101.PRE bgne-20170630_pre.xml EX-101.PRE 360356
Mailing Address C/O MOURANT OZANNES CORPORATE SERVICES 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT OZANNES CORPORATE SERVICES 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37686 | Film No.: 171017832
SIC: 2834 Pharmaceutical Preparations